{"disease":{"id":"eosinophilic-granulomatosis-with-polyangiitis-egpa","name":"eosinophilic granulomatosis with polyangiitis egpa"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07444567","title":"Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":230,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT02807103","title":"Rituximab in Eosinophilic Granulomatosis With Polyangiitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03482479","title":"Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT06512883","title":"A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":14,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}